RXi Pharmaceuticals Corp. appointed Jonathan Freeman to its board as an independent director, with immediate effect.
Freeman also serves as the chief business officer of privately held Vedanta Biosciences.
RXi Pharmaceuticals names board member
Identifying PPE Suppliers During the Pandemic
Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage
COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021
Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective
RXi Pharmaceuticals names board member
- Author Mark Louie Bonayon
- Theme Healthcare & Pharmaceuticals
- Author
- Mark Louie Bonayon
- Theme
- Healthcare & Pharmaceuticals